Gilead to fork over $1.25B, pay 3% royalty on blockbuster Biktarvy in GSK patent settlement

Gilead to fork over $1.25B, pay 3% royalty on blockbuster Biktarvy in GSK patent settlement
esagonowsky
Tue, 02/01/2022 – 16:28